VIDEO: Type 1 diabetes screening, monitoring reduce DKA rates for kids
Click Here to Manage Email Alerts
SAN DIEGO — In this video exclusive, Anastasia Albanese-O’Neill, PhD, APRN, RN, CDCES, discusses the need for type 1 diabetes screening and monitoring now that a therapy to delay the disease is available.
Albanese-O’Neill, director of community screening and clinical trial education at JDRF and a Healio | Endocrine Today Editorial Board Member, notes that rates of diabetic ketoacidosis are unacceptably high but can be lowered by screening for diabetes and educating families about risks. She highlights the importance of developing guidelines for monitoring people with positive antibodies, recognizing symptoms and preventing complications.
“There is a movement throughout the field ... to bring consensus around what we should do in terms of monitoring people who have identified, positive antibodies for type 1 diabetes,” Albanese-O’Neill told Healio. “And this should help, ultimately, with the care provided to these individuals globally.”
Collapse
Healio Interviews
Read more about
Click Here to Manage Email Alerts